Free Pick from Jeff Brown: “Buy S.C.G .”
Jeff Brown picked Tesla in 2018 before it jumped 1,390%. He picked Nvidia before it jumped 3,545%. And he picked Bitcoin before it skyrocketed 22,750%.

And now he’s saying S.C.G. will be the next big tech play. He’s not the only one. Apple’s CEO even called it “the next big thing.”
Click here and get the name and ticker symbol!
Thomas J. Spoerel, insider at Becton, Dickinson and
Thomas J. Spoerel Insider Alerts

Get notified the next time Thomas J. Spoerel buys or sells Becton, Dickinson and stock. Enter your email address below to get our daily insider buying and selling report.

Thomas J. Spoerel Insider Information

Thomas J. Spoerel is Chief Accounting Officer, Principal Accounting Officer, Vice President, Controller of the Company. Mr. Spoerel joined BD in September 2015 as Vice President Finance and Deputy Controller, and became Vice President Finance and Controller in December 2018. Prior to joining BD, Mr. Spoerel served as Vice President Finance and Corporate Controller of Catalent, Inc.

What is Thomas J. Spoerel's net worth?

The estimated net worth of Thomas J. Spoerel is at least $340,049.55 as of August 6th, 2021. Mr. Spoerel owns 1,285 shares of Becton, Dickinson and stock worth more than $340,050 as of January 22nd. This net worth approximation does not reflect any other assets that Mr. Spoerel may own. Learn More.

How do I contact Thomas J. Spoerel?

The corporate mailing address for Mr. Spoerel and other Becton, Dickinson and executives is 1 BECTON DRIVE, FRANKLIN LAKES NJ, 07417. Becton, Dickinson and can also be reached via phone at (201) 847-6800.

Has Thomas J. Spoerel been buying or selling shares of Becton, Dickinson and?

Thomas J. Spoerel has not been actively trading shares of Becton, Dickinson and during the last ninety days. Most recently, Thomas J. Spoerel sold 266 shares of the business's stock in a transaction on Friday, August 6th. The shares were sold at an average price of $242.30, for a transaction totalling $64,451.80. Following the completion of the sale, the vice president now directly owns 1,285 shares of the company's stock, valued at $311,355.50.

Who are Becton, Dickinson and's active insiders?

Becton, Dickinson and's insider roster includes Claire Fraser (Director), Betty Larson (EVP), James Lim (EVP), Rebecca Rimel (Director), and Thomas Spoerel (VP).

Are insiders buying or selling shares of Becton, Dickinson and?

During the last year, insiders at the medical instruments supplier sold shares 12 times. They sold a total of 16,486 shares worth more than $4,163,633.82. The most recent insider tranaction occured on December, 16th when EVP Betty D Larson sold 3,341 shares worth more than $851,955.00. Insiders at Becton, Dickinson and own 0.5 % of the company.

Information on this page was last updated on 12/16/2021.

Thomas J. Spoerel Insider Trading History at Becton, Dickinson and

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/6/2021Sell266$242.30$64,451.801,285View SEC Filing Icon  
See Full Table

Thomas J. Spoerel Buying and Selling Activity at Becton, Dickinson and

This chart shows Thomas J. Spoerel's buying and selling at Becton, Dickinson and by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Becton, Dickinson and Company Overview

Becton, Dickinson and logo
Becton, Dickinson & Co. is a medical technology company. The firm engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, the pharmaceutical industry, and the general public. It operates through the following segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment produces medical technologies and devices that are used to help improve healthcare delivery. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens; and instruments and reagent systems to detect infectious diseases, healthcare-associated infections, and cancers. The BD Interventional segment offers vascular, urology, oncology, and surgical specialty products to hospitals, individual healthcare professionals, extended care facilities, alternate site facilities, and patients via Homecare business. The company was founded by Maxwell W. Becton and Fairleigh S. Dickinson in 1897 and is headquartered in Franklin Lakes, NJ.
Read More

Today's Range

Now: $264.63
Low: $262.87
High: $266.65

50 Day Range

MA: $251.25
Low: $237.14
High: $264.63

2 Week Range

Now: $264.63
Low: $235.13
High: $268.55

Volume

1,675,985 shs

Average Volume

1,358,852 shs

Market Capitalization

$75.43 billion

P/E Ratio

38.63

Dividend Yield

1.32%

Beta

0.72
Free Pick from Jeff Brown: “Buy S.C.G .”
Jeff Brown picked Tesla in 2018 before it jumped 1,390%. He picked Nvidia before it jumped 3,545%. And he picked Bitcoin before it skyrocketed 22,750%.

And now he’s saying S.C.G. will be the next big tech play. He’s not the only one. Apple’s CEO even called it “the next big thing.”
Click here and get the name and ticker symbol!